WASHINGTON, D.C. (June 6, 2005) -- Golf legend Arnold Palmer and musician/activist Melissa Etheridge, both cancer survivors, will share their stories of coping with, surviving and raising public awareness about this deadly disease at BIO 2005 in the Pennsylvania Convention Center.
Palmer and Etheridge will speak Wednesday, June 22, 2005 at the plenary luncheon “Survivors in Our Sights: The Public Face of Health Care” scheduled from noon to 2 p.m. Etheridge will perform two songs.
A world-famous golfer and sportsman, Palmer is also a business executive, advertising spokesman, aviator, golf course designer and consultant. He has amassed 92 championships in professional golf competitions of national or international stature. Sixty-two of the victories came on the U.S. PGA Tour, beginning with the 1955 Canadian Open.
Etheridge, a two-time Grammy winner, uses her fame to support numerous causes. She will be releasing a greatest hits album titled “Greatest Hits – The Road Less Traveled” with three never-before released songs Oct. 18. She released her eighth studio album, “Lucky,” Feb. 10.
BIO 2005, the Biotechnology Industry Organization’s annual convention, is June 19-22, 2005 in Philadelphia at the Pennsylvania Convention Center. The convention is expected to draw 18,000 CEOs, policymakers, journalists, venture capitalists and the like for three days of networking and learning.
Boasting the theme “Imagine, Collaborate, Innovate,” BIO 2005 will feature more than 150 educational sessions and workshops on finance, partnering, R&D, science and policy. Meanwhile, the popular business forum will accommodate approximately 200 company presentations and 4,000 partnering meetings, while more than 1,450 exhibiting organizations from around the world will display highlights of their technology in the exhibit hall.
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products.